Literature DB >> 27981519

Craniopharyngiomas: a life-changing tumor.

Pietro Mortini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27981519     DOI： 10.1007/s12020-016-1192-2

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  10 in total

1.  Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up.

Authors:  Hermann L Müller; Ursel Gebhardt; Carmen Teske; Andreas Faldum; Isabella Zwiener; Monika Warmuth-Metz; Torsten Pietsch; Fabian Pohl; Niels Sörensen; Gabriele Calaminus
Journal:  Eur J Endocrinol       Date:  2011-04-13       Impact factor: 6.664

2.  Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas.

Authors:  Pietro Mortini; Filippo Gagliardi; Michele Bailo; Alfio Spina; Andrea Parlangeli; Andrea Falini; Marco Losa
Journal:  Endocrine       Date:  2015-07-16       Impact factor: 3.633

3.  Resection of tumors of the third ventricle involving the hypothalamus: effects on body mass index using a dedicated surgical approach.

Authors:  Pietro Mortini; Filippo Gagliardi; Michele Bailo; Nicola Boari; Antonella Castellano; Andrea Falini; Marco Losa
Journal:  Endocrine       Date:  2016-09-29       Impact factor: 3.633

Review 4.  Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.

Authors:  N Karavitaki; C Brufani; J T Warner; C B T Adams; P Richards; O Ansorge; B Shine; H E Turner; J A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2005-04       Impact factor: 3.478

5.  Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series.

Authors:  Pietro Mortini; Marco Losa; Gabriella Pozzobon; Raffaella Barzaghi; Marco Riva; Stefania Acerno; Diana Angius; Giovanna Weber; Giuseppe Chiumello; Massimo Giovanelli
Journal:  J Neurosurg       Date:  2011-01-07       Impact factor: 5.115

6.  Morbidity of transcallosal and transcortical approaches to lesions in and around the lateral and third ventricles: a single-institution experience.

Authors:  Brian D Milligan; Fredric B Meyer
Journal:  Neurosurgery       Date:  2010-12       Impact factor: 4.654

7.  Long-term outcomes for surgically resected craniopharyngiomas.

Authors:  J Duff; F B Meyer; D M Ilstrup; E R Laws; C D Schleck; B W Scheithauer
Journal:  Neurosurgery       Date:  2000-02       Impact factor: 4.654

8.  Craniopharyngioma in adults and children: a study of 122 surgical cases.

Authors:  Rémy Van Effenterre; Anne-Laure Boch
Journal:  J Neurosurg       Date:  2002-07       Impact factor: 5.115

9.  Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?

Authors:  C J De Vile; D B Grant; B E Kendall; B G Neville; R Stanhope; K E Watkins; R D Hayward
Journal:  J Neurosurg       Date:  1996-07       Impact factor: 5.115

Review 10.  Surgical strategies and modern therapeutic options in the treatment of craniopharyngiomas.

Authors:  Pietro Mortini; Filippo Gagliardi; Nicola Boari; Marco Losa
Journal:  Crit Rev Oncol Hematol       Date:  2013-08-07       Impact factor: 6.312
  10 in total
  3 in total

Review 1.  Excess mortality after craniopharyngioma treatment: are we making progress?

Authors:  Nidan Qiao
Journal:  Endocrine       Date:  2018-12-19       Impact factor: 3.633

2.  Integrin α6 Indicates a Poor Prognosis of Craniopharyngioma through Bioinformatic Analysis and Experimental Validation.

Authors:  Yanfei Jia; Wentao Wu; Youchao Xiao; Kefan Cai; Songbai Gui; Qiang Li; Tian Li
Journal:  J Oncol       Date:  2022-10-11       Impact factor: 4.501

3.  Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity.

Authors:  Marco Losa; Pietro Mortini; Alberto Luigi Gallotti; Lina Raffaella Barzaghi; Luigi Albano; Marzia Medone; Filippo Gagliardi
Journal:  Pituitary       Date:  2021-07-08       Impact factor: 4.107
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.